Federal
Register Notices > Manufacturers 2008
>
American Radiolabeled Chemical, Inc.
FR Doc E8-17971[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45785] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-95]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on June 11, 2008, American Radiolabeled Chemical, Inc., 101 Arc
Drive, St. Louis, Missouri 63146, made application by renewal to the Drug
Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Gamma hydroxybutyric acid (2010)
|
I
|
Ibogaine (7260)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Dimethyltryptamine (7435)
|
I
|
1-[1-(2-Thienyl)cyclohexyl]piper-idine (7470)
|
I
|
Dihydromorphine (9145)
|
I
|
Normorphine (9313)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Amobarbital (2125)
|
II
|
Phencyclidine (7471)
|
II
|
Phenylacetone (8501)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Ecgonine (9180)
|
II
|
Hydrocodone (9193)
|
II
|
Meperidine (9230)
|
II
|
Metazocine (9240)
|
II
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
Morphine (9300)
|
II
|
Oripavine (9330)
|
II
|
Thebaine (9333)
|
II
|
Oxymorphone (9652)
|
II
|
Phenazocine (9715)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances as radiolabeled compounds for biochemical research.
Any other such applicant, and any person who is presently registered with DEA
to manufacture such substances, may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in quintuplicate,
to the Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia
22152; and must be filed no later than October 6, 2008.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-17971 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|